Tag - ips

 
 

IPS

Japan Times
JAPAN / Science & Health
Apr 18, 2019
Patients doing well after landmark 2017 retina transplants via donor iPS cells in Japan
Of the five, four have maintained their level of visual acuity after the operations, while one experienced an improvement in their vision.
Japan Times
JAPAN / Science & Health
Mar 6, 2019
Japan's health ministry approves world's first trials for using iPS cells to treat corneal disease
The study, to be conducted by a team of researchers from Osaka University, will be the sixth time the government has authorized clinical studies using iPS cells.
Japan Times
JAPAN / Science & Health
Nov 14, 2018
Keio researchers plan to treat spinal cord injuries with stem cells
Keio University is poised to conduct the world's first treatment of patients who have sustained spinal cord injuries using induced pluripotent stem cells, sources said Tuesday.
Japan Times
JAPAN / Science & Health
Nov 9, 2018
Kyoto University performs world's first iPS cell transplant for Parkinson's
Researchers hope to develop the treatment into a method that can be covered under Japan's health insurance system.
JAPAN / Science & Health
Sep 24, 2018
Fujifilm plans iPS-based trials to treat complications from bone marrow transplants
Fujifilm Corp. aims to start clinical trials with artificially derived stem cells next year to prevent serious complications from bone marrow transplants used to treat leukemia, company officials say.
Japan Times
JAPAN / Science & Health
Sep 22, 2018
Blood transfusions with iPS cells OK'd by Japanese health ministry
The advanced treatment is expected to give people with uncontrollable diseases a better way to increase their platelet counts at a time when blood donors are drying up.
Japan Times
JAPAN / Science & Health
Jul 30, 2018
Kyoto team pits iPS cells against Parkinson's disease
A Kyoto University research team will begin a clinical test this week using induced pluripotent stem cells to treat Parkinson's disease, in what will be the world's first application of iPS technology to the progressive neurological disorder.
Japan Times
JAPAN / Science & Health
May 16, 2018
Japan OKs first clinical study of iPS cell-based heart treatment
The world's first clinical study for treating heart failure with so-called iPS cells could start in Japan in the coming months after the health ministry approved a plan by Osaka University.
Japan Times
BUSINESS
Apr 23, 2018
Putin's turf war with Telegram escalates as Russia blocks IPs
Russia's communications regulator blocked some Alphabet Inc. internet addresses, blaming the U.S. owner of Google for helping Pavel Durov's Telegram Messenger LLP service evade government blocking.
JAPAN / Science & Health
Mar 9, 2018
Osaka University OKs world's first test of iPS-cell-based heart failure treatment
A Japanese team of physicians won approval Friday from an Osaka University panel for its plan to carry out the world's first clinical study for treating heart failure with sheets of cardiac muscle cells created from so-called iPS cells.
Japan Times
JAPAN / Science & Health
Jan 25, 2018
Nobel winner Shinya Yamanaka to donate salary after iPS research scandal at Kyoto University
Nobel laureate Shinya Yamanaka, who heads a research institute for induced pluripotent stem cells at Kyoto University, is considering donating his salary to the facility to take responsibility for data fabrication in a paper by one of its researchers, sources have said.
Japan Times
JAPAN / Science & Health
Jan 23, 2018
Unstable work seen as a factor as Kyoto University admits iPS researcher falsified data in paper
Experts say unstable employment conditions faced by scientists are behind the string of research-related scandals in the nation.
Japan Times
JAPAN / Science & Health
Jan 17, 2018
First serious adverse reaction to iPS-derived retinal cell transplant reported
A patient who underwent transplant surgery using retinal cells derived from so-called iPS cells from another person has suffered a swollen retina, the team that carried out the world's first clinical trial of the procedure said Tuesday.
Japan Times
JAPAN / FINDING COMMON GROUND
Dec 31, 2017
Japan's need for foreign labor to get dire as 2050 nears
As the nation struggles with a shortage of workers and an aging population, experts expect Japan to develop a severe labor shortage around mid-century.
Japan Times
JAPAN / Science & Health
Nov 22, 2017
Japanese scientists find new drug combo that may be key to treating Alzheimer's
A team of Japanese researchers has found a new drug combination that reduces amyloid beta protein, believed to play a key role in causing Alzheimer's disease, by using stem cells derived from patients, Kyoto University announced Tuesday.
JAPAN / Science & Health
Sep 5, 2017
Compound normalizes brain structure and function in mice with Down syndrome, Kyoto researchers say
The findings could lead to the development of drugs to treat Down syndrome and other conditions, including Alzheimer's and Parkinson's diseases.
Japan Times
JAPAN / Science & Health
Aug 31, 2017
Kyoto University reprograms stem cells to fight Parkinson's in monkeys, a breakthrough for therapy
Japanese researchers successfully engineered cells to relieve Parkinson's symptoms in clinical trials, taking a step closer to a potential cure.
Japan Times
JAPAN / Science & Health
Aug 25, 2017
30% of Japanese may reject transplants of iPS cells derived from others: study
Some 30 percent of Japanese may experience rejection after receiving transplants of cells developed from induced pluripotent stem (iPS) cells derived from someone other than the patient, a Japanese research team has found.
Japan Times
JAPAN / Science & Health
Aug 18, 2017
Fertile offspring produced from sterile mice using iPS cells
A team of Japanese and British scientists has succeeded in producing fertile offspring from sterile mice made with a chromosomal abnormality by using induced pluripotent stem cells, better known as iPS cells, Kyoto University said Friday.
Japan Times
JAPAN / Science & Health
Aug 7, 2017
World's first method for mass-producing platelets from iPS cells unveiled by Kyoto startup
A Kyoto startup unveils a way to mass-produce platelets, a key component in clotting, that could reduce doctors' dependency on donated blood to minimize bleeding.

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan